Evidence map›Paper›PMID 34331083›Full record

ArticleExperimental brain research2021

Morc1 as a potential new target gene in mood regulation: when and where to find in the brain.

Annakarina Mundorf, Jennifer Koch, Nadja Kubitza, Selina C Wagner, Michaela Schmidt, Peter Gass, Nadja Freund

Open access · hybridAbstract read
In one paragraph

Article in Experimental brain research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Annakarina MundorfDivision of Experimental and Molecular Psychiatry, Department of Psychiatry, Psychotherapy and Preventive Medicine, LWL University Hospital, Ruhr-University Bochum, Ruhr-Universität Bochum, Experimentelle Und Molekulare Psychiatrie, Universitätsstr. 150, 44801, Bochum, Germany.ORCID http://orcid.org/0000-0002-3667-5339
Jennifer KochDivision of Experimental and Molecular Psychiatry, Department of Psychiatry, Psychotherapy and Preventive Medicine, LWL University Hospital, Ruhr-University Bochum, Ruhr-Universität Bochum, Experimentelle Und Molekulare Psychiatrie, Universitätsstr. 150, 44801, Bochum, Germany.
Nadja KubitzaDivision of Experimental and Molecular Psychiatry, Department of Psychiatry, Psychotherapy and Preventive Medicine, LWL University Hospital, Ruhr-University Bochum, Ruhr-Universität Bochum, Experimentelle Und Molekulare Psychiatrie, Universitätsstr. 150, 44801, Bochum, Germany.
Selina C WagnerDivision of Experimental and Molecular Psychiatry, Department of Psychiatry, Psychotherapy and Preventive Medicine, LWL University Hospital, Ruhr-University Bochum, Ruhr-Universität Bochum, Experimentelle Und Molekulare Psychiatrie, Universitätsstr. 150, 44801, Bochum, Germany.
Michaela SchmidtDepartment of Psychiatry and Psychotherapy, Central Institute of Mental Health Mannheim (ZI), Medical Faculty of Mannheim, University of Heidelberg, Mannheim, Germany.
Peter GassDepartment of Psychiatry and Psychotherapy, Central Institute of Mental Health Mannheim (ZI), Medical Faculty of Mannheim, University of Heidelberg, Mannheim, Germany.
Nadja FreundDivision of Experimental and Molecular Psychiatry, Department of Psychiatry, Psychotherapy and Preventive Medicine, LWL University Hospital, Ruhr-University Bochum, Ruhr-Universität Bochum, Experimentelle Und Molekulare Psychiatrie, Universitätsstr. 150, 44801, Bochum, Germany. Nadja.Freund@rub.de.ORCID http://orcid.org/0000-0002-8857-4820
Ruhr University Bochum · DEHeidelberg University · DEMSH Medical School Hamburg – University of Applied Sciences and Medical University · DEUniversity Hospitals of the Ruhr-University of Bochum · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent animal and human studies connected the Morc family CW-type zinc finger 1 (Morc1) gene with early life stress and depression. Moreover, the Morc superfamily is related to epigenetic regulation in diverse nuclear processes. So far, the Morc1 gene was mainly studied in spermatogenesis, whereas its distribution and function in the brain are still unknown. In a first attempt to characterize Morc1 in the brain, we performed a Western Blot analysis as well as a real-time PCR analysis during different stages of development. Additionally, we detected Morc1 mRNA using real-time PCR in different mood-regulating brain areas in adult rats. We found that MORC1 protein as well as Morc1 mRNA is already expressed in the brain at embryonic day 14 and is stably expressed until adulthood. Furthermore, Morc1 mRNA is present in many important brain areas of mood regulation like the medial prefrontal cortex, the nucleus accumbens, the hippocampus, the hypothalamus, and the amygdala. The ample distribution in the brain and its molecular structure as a zinc finger protein indicate that Morc1 might act as a transcription factor. This function and its expression in mood-regulating areas already in the early brain development turn Morc1 into a possible candidate gene for mediating early life stress and depression.

Indexed as

Epigenesis, GeneticTranscription FactorsAnimalsBrainHippocampusMaleRatsRNA, MessengerRNA, MessengerTranscription FactorsDepressionDevelopmentEarly life stressMood regulationRat

Identifiers

PMID34331083
PMCPMC8536634
OpenAlexW3185923280

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.